HK:2196 Stock Latest News
Company AnnouncementsFosun Subsidiary Receives Clinical-Trial Approval for FAP PET Drug4d ago
Company AnnouncementsFosun Pharmaceutical Subsidiary Initiates Phase II FXR0906 Trial4d ago
Company AnnouncementsFosun Kairos Initiates Phase II Trial of FKC516 in Chinese Mainland1w ago
Company AnnouncementsFosun Pharma Starts Phase III Trial of FXS6837 in China2w ago
Company AnnouncementsFosun Pharma Issues Unaudited Q3 2026 Report With Governance Assurances3w ago
Pre-EarningsSFOSF Upcoming Earnings Report: What to Expect?3w ago
Company AnnouncementsFosun Pharma Launches Up to HK$1 Billion H-Share Buyback Plan2M ago
Company AnnouncementsFosun Pharma Wins China Approval for New Luvometinib Indication2M ago
Company AnnouncementsFosun Pharma Grants Reserved A Share Options Under 2025 Incentive Scheme2M ago
Company AnnouncementsFosun Pharma Grants New H Share RSUs to 100 Employees Under 2025 Incentive Scheme2M ago
Company AnnouncementsFosun Pharma Unit Secures Exclusive Rights to Advanced Bispecific Antibody Drug2M ago
Company AnnouncementsFosun Pharma Subsidiary Advances COPD Drug FXS7553 Into Phase II Trial in China3M ago
Company AnnouncementsFosun Pharma Sets August Board Meeting to Approve 2026 Interim Results3M ago
Company AnnouncementsFosun Pharma Wins NMPA Approval for New Levosalbutamol Nebuliser Therapy3M ago
Company AnnouncementsFosun Pharma Subsidiary Wins China Approval for Heart Failure Injection3M agoCompany AnnouncementsFosun Pharma Subsidiary Wins Approval for Pediatric Constipation Drug in China3M ago
Company AnnouncementsFosun Pharma Subsidiary Wins Approval for New Type 2 Diabetes Combination Drug3M ago



